Cargando…

Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial

Detalles Bibliográficos
Autores principales: Xu, Fengrui, Zhang, Yang, Miao, Zhanhui, Zeng, Xiaohua, Wu, Biao, Cai, Li, Liu, Jinping, Wang, Shusen, Hu, Xichun, Zheng, Wenbo, Chen, Zhiyue, Yang, Qing, Jiang, Zefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290653/
https://www.ncbi.nlm.nih.gov/pubmed/32566597
http://dx.doi.org/10.21037/atm-2020-23
_version_ 1783545728002424832
author Xu, Fengrui
Zhang, Yang
Miao, Zhanhui
Zeng, Xiaohua
Wu, Biao
Cai, Li
Liu, Jinping
Wang, Shusen
Hu, Xichun
Zheng, Wenbo
Chen, Zhiyue
Yang, Qing
Jiang, Zefei
author_facet Xu, Fengrui
Zhang, Yang
Miao, Zhanhui
Zeng, Xiaohua
Wu, Biao
Cai, Li
Liu, Jinping
Wang, Shusen
Hu, Xichun
Zheng, Wenbo
Chen, Zhiyue
Yang, Qing
Jiang, Zefei
author_sort Xu, Fengrui
collection PubMed
description
format Online
Article
Text
id pubmed-7290653
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-72906532020-06-19 Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial Xu, Fengrui Zhang, Yang Miao, Zhanhui Zeng, Xiaohua Wu, Biao Cai, Li Liu, Jinping Wang, Shusen Hu, Xichun Zheng, Wenbo Chen, Zhiyue Yang, Qing Jiang, Zefei Ann Transl Med Erratum AME Publishing Company 2020-05 /pmc/articles/PMC7290653/ /pubmed/32566597 http://dx.doi.org/10.21037/atm-2020-23 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Erratum
Xu, Fengrui
Zhang, Yang
Miao, Zhanhui
Zeng, Xiaohua
Wu, Biao
Cai, Li
Liu, Jinping
Wang, Shusen
Hu, Xichun
Zheng, Wenbo
Chen, Zhiyue
Yang, Qing
Jiang, Zefei
Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial
title Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial
title_full Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial
title_fullStr Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial
title_full_unstemmed Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial
title_short Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial
title_sort erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase iii trial
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290653/
https://www.ncbi.nlm.nih.gov/pubmed/32566597
http://dx.doi.org/10.21037/atm-2020-23
work_keys_str_mv AT xufengrui erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT zhangyang erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT miaozhanhui erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT zengxiaohua erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT wubiao erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT caili erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT liujinping erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT wangshusen erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT huxichun erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT zhengwenbo erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT chenzhiyue erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT yangqing erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial
AT jiangzefei erratumtoefficacyandsafetyofmecapegfilgrastimforprophylaxisofchemotherapyinducedneutropeniainpatientswithbreastcancerarandomizedmulticenteractivecontrolledphaseiiitrial